Technical analysis of Predictive Oncology Inc. (POAI): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline.
Price Performance
| 1 month | +0.00% |
| 3 months | +0.00% |
| Year-to-date | +0.00% |
| 1 year | -60.28% |
| 3 years | -87.25% |
52-Week Range
| 52-week High | $45.90 |
| 52-week Low | $3.88 |
| Avg Volume (90d) | 77K |
Technical Indicators
| SMA 50 | $8.42 |
| SMA 200 | $13.27 |
| 30-day Volatility (annualised) | 121.7% |
| Price vs SMA 50 | -29.3% |
| Price vs SMA 200 | -55.2% |
Price
| Price | $4.91 |
| Market Cap | $4M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.84 |
| EV / EBITDA | -0.50 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 1.45 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 2.62 |
Related companies: AIM · AMIX · BNGO · CYCN · GBS · HSCS · KTTA
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of POAI: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks